Respiratory Distress Syndrome

25 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Respiratory Distress Syndrome
Treatment and conditionWhere it standsTrials
a wake prone positioning for respiratory distress syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Apremilast for respiratory distress syndromePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Atibuclimab for respiratory distress syndromePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Aviptadil for respiratory distress syndromePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Awake prone positioning for respiratory distress syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Cenicriviroc for respiratory distress syndromePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cyclosporine for respiratory distress syndromePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cyproheptadine for respiratory distress syndromePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dornase alfa for respiratory distress syndromePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
EIT-Group for respiratory distress syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Famotidine + Celecoxib for respiratory distress syndromePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Hydroxychloroquine for respiratory distress syndromePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Hydroxychloroquine Pill + Azithromycin Pill for respiratory distress syndromePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ibuprofen for respiratory distress syndromeTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Icatibant for respiratory distress syndromePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Imatinib Mesylate for respiratory distress syndromePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
LEAF-4L6715 for respiratory distress syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Narsoplimab for respiratory distress syndromePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Prone decubitus for respiratory distress syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Prone Position for respiratory distress syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
prone positioning for respiratory distress syndromeTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Prone Positioning (PP) for respiratory distress syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
Solizmestrocel for respiratory distress syndromePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)2
UC-MSC and Secretome for respiratory distress syndromePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Wharton's jelly derived Mesenchymal stem cells. for respiratory distress syndromeTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1